Diferencia entre revisiones de «Template:Cervicitis Urethritis Antibiotics»

 
(No se muestra una edición intermedia del mismo usuario)
Línea 1: Línea 1:
{{Presumed GC/chlamydia of cervix, urethra, or rectum}}
{{Presumed GC/chlamydia of cervix, urethra, or rectum}}


====Partner Treatment====
===Associated [[Bacterial Vaginosis]] or [[Trichomonas vaginalis]]===
*Gonorrhea
**[[Cefixime]] 800mg PO x 1
*Chlamydia
**Nonpregnant: [[doxycycline]] 100mg PO BID x 7 days, '''OR'''
**Pregnant: [[azithromycin]] 1g PO x 1
 
====Associated [[Bacterial Vaginosis]] or [[Trichomonas vaginalis]]====
{{Trichomonas antibiotics}}
{{Trichomonas antibiotics}}

Revisión actual - 19:10 23 dic 2020

Presumed GC/chlamydia of cervix, urethra, or rectum (uncomplicated)[1]

Typically, treatment for both gonorrhea and chlamydia is indicated, if one entity is suspected.

Standard


Ceftriaxone contraindicated

^Additional chlamydia coverage only needed if treated with cefixime only

Partner Treatment

Associated Bacterial Vaginosis or Trichomonas vaginalis

Non-Pregnant

Pregnant

Only treat if the patient is symptomatic

Sexual Partner Treatment

  1. Cyr SS et al. Update to CDC's Treatment Guidelines for Gonococcal Infection, 2020. MMWR. Center for Disease Control and Prevention. 2020. 69(50):1911-1916
  2. Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70(No. RR-4):1–187. DOI: http://dx.doi.org/10.15585/mmwr.rr7004a1external icon
  3. CDC Trichomoniasis 2021. https://www.cdc.gov/std/treatment-guidelines/trichomoniasis.htm
  4. Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021;70(No. RR-4):1–187. DOI: http://dx.doi.org/10.15585/mmwr.rr7004a1external icon